HSBC Holdings’s Telix Pharmaceuticals TLX Stock Holding History
Bought
Maintained
Sold
Other funds holding TLX
HSBC Holdings's TLX Position: Q3 2026 in Review
HSBC Holdings reduced its Telix Pharmaceuticals (TLX) stake by 23% in Q3 2026, selling an estimated $42.6K and leaving 12,730 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.
HSBC Holdings first reported a position in TLX in Q2 2026 and has held it in 2 quarters since. The position peaked at $190K in Q2 2026. 74 funds tracked by Wall St. Rank hold TLX as of Q3 2026.
- HSBC Holdings held 12,730 shares of Telix Pharmaceuticals worth $140K as of Q3 2026.
- HSBC Holdings sold 3,758 Telix Pharmaceuticals shares in Q3 2026, an estimated $42.6K.
- Telix Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2719 holding.
- HSBC Holdings first reported a position in Telix Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- HSBC Holdings's Telix Pharmaceuticals position peaked at $190K in Q2 2026.
- 74 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.